4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-22-013173
Chief Development Officer acquired 64,395 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Machatha Stephen Chief Development Officer | 2022-03-30 | Grant or award | +64,395 | 87,658 | D | ||
| Derivatives | |||||||
| Machatha Stephen Chief Development Officer | 2022-03-30 | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | D | ||
Loading xslF345X03/doc4.xml…